Hypertension Drugs Tied To Higher Cancer Risk
Hypertension drugs including telmisartan, sold by Boehringer Ingelheim GmbH under the brand name Micardis, have been linked to an increased risk of cancer, according to a study published Monday....To view the full article, register now.
Already a subscriber? Click here to view full article